Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
1994 3
1995 6
1996 2
1997 1
1998 2
1999 5
2000 2
2002 1
2003 1
2005 4
2006 1
2007 5
2008 4
2009 4
2010 2
2011 1
2012 1
2013 2
2014 1
2015 4
2016 2
2017 1
2018 1
2020 2
2021 3
2022 1
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.
Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, Mannel RS, DeGeest K, Hartenbach EM, Baergen R; Gynecologic Oncology Group. Ozols RF, et al. Among authors: hartenbach em. J Clin Oncol. 2003 Sep 1;21(17):3194-200. doi: 10.1200/JCO.2003.02.153. Epub 2003 Jul 14. J Clin Oncol. 2003. PMID: 12860964 Corrected and republished. Clinical Trial.
Metastatic placental site trophoblastic tumor.
Twiggs LB, Hartenbach E, Saltzman AK, King LA. Twiggs LB, et al. Among authors: hartenbach e. Int J Gynaecol Obstet. 1998 Apr;60 Suppl 1:S51-5. Int J Gynaecol Obstet. 1998. PMID: 9833615 Review.
Outpatient vaginal cuff brachytherapy for endometrial cancer.
Petereit DG, Tannehill SP, Grosen EA, Hartenbach EM, Schink JC. Petereit DG, et al. Among authors: hartenbach em. Int J Gynecol Cancer. 1999 Nov;9(6):456-462. doi: 10.1046/j.1525-1438.1999.99061.x. Int J Gynecol Cancer. 1999. PMID: 11240811
Venous thromboembolism prophylaxis: is two better than one?
Einstein MH, Hartenbach EM. Einstein MH, et al. Among authors: hartenbach em. Gynecol Oncol. 2007 Sep;106(3):437-8. doi: 10.1016/j.ygyno.2007.07.066. Gynecol Oncol. 2007. PMID: 17761279 No abstract available.
65 results